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Abstract: Repetitive transcranial magnetic stimulation (rTMS) may be effective for enhancing cognitive
functioning. In this review, we aimed to systematically evaluate the effects of rTMS on attention in
psychiatric diseases. In particular, we searched PubMed and Embase to examine the effectiveness of
rTMS administered to the dorsolateral prefrontal cortex (DLPFC) on this specific cognitive domain.
The search identified 24 articles, 21 of which met inclusion and exclusion criteria. Among them, nine
were conducted in patients with depression, four in patients with schizophrenia, three in patients
with autism spectrum disorder (ASD), two in patients with attention deficit hyperactivity disorder,
one each in patients with Alzheimer’s disease and in patients with alcohol or methamphetamine
addiction. No evidence for cognitive adverse effects was found in all the included rTMS studies.
Several studies showed a significant improvement of attentional function in patients with depression
and schizophrenia. The beneficial effects on attention and other executive functions suggest that
rTMS has the potential to target core features of ASD. rTMS may influence the attentional networks in
alcohol-dependent and other addicted patients. We also reviewed and discussed the studies assessing
the effects of rTMS on attention in the healthy population. This review suggests that prefrontal rTMS
could exert procognitive effects on attention in patients with many psychiatric disorders.
Keywords: repetitive transcranial magnetic stimulation; attention; dorsolateral prefrontal cortex;
depression; schizophrenia; autism
1. Introduction
Attention is a cognitive and behavioral process that selectively focuses on individual aspects of
subjective or objective information, allowing through voluntary top-down and automatic bottom-up
mechanisms to selectively process or inhibit contents from the multiplicity of sensory inputs over
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different domains [1–3]. Attention facilitates or impairs other cognitive functions, such as memory,
language, problem solving, and reflects complex interactions of multiple independent systems
distributed within the brain [4,5].
Psychiatric disorders can also lead to attention deficits. Dysfunctions in attentional processes
and selective set-shifting have been reported in depressed individuals [6]. Schizophrenia presents
with positive clinical features but also with negative clinical features, such as attentional deficits [7].
In adult patients with attention deficit hyperactivity disorder (ADHD), cognitive disturbances are
more pronounced than in the pediatric population [8] and are most evident as deficiencies of executive
functions and attention [9,10]. In autism, the selective attention has been shown to be impaired even in
situations where behavior is normal; especially a deficit in rapid attention shifting has been observed
in behavioral tasks shifting between sensory modalities, spatial locations, and object features [11–13].
Attention does not localize anatomically [14] and is therefore difficult to study. However, frontal
regions are particularly active during tasks of alerting attention [5]. Indeed, neuroimaging studies
have demonstrated the engagement of the left dorsolateral prefrontal cortex (DLPFC) in executive
functioning, and more specifically during selective attention. In particular, a functional magnetic
resonance imaging (fMRI) study indicates the posterior DLPFC was active during a bimodal divided
attention condition [15]. The posterior DLPFC may support the increased working memory load
associated with divided, compared to selective attention.
If delivered repetitively, transcranial magnetic stimulation (TMS) can influence brain function
and induce changes in neuroplasticity, also in brain regions recruited by attentional processes. Indeed,
repetitive TMS (rTMS) can modulate cortical excitability, inducing lasting effects [16]. Therefore,
rTMS has evolved into a powerful neuroscientific tool allowing to interfere transiently with specific
brain functions.
A number of rTMS studies which targeted the DLPFC have shown significant improvements in
cognitive function scores using both short- and long-term stimulation paradigms [17–21]. It might be
of interest to explore whether rTMS could serve as an intervention in disorders with attention deficits.
A number of studies has specifically targeted attention, while many others assessed broader effects.
The aim of this review was to summarize the most specific studies assessing the effects of rTMS
over DLPFC on attentional processes in subjects with psychiatric disorders.
2. Transcranial Magnetic Stimulation
rTMS is a noninvasive and safe brain stimulation technique that uses brief, intense pulses of
electric current delivered to a coil placed on the subject’s head in order to generate an electric field in
the brain via electromagnetic induction. rTMS has been proven to influence cortical excitability and the
metabolic activity of neurons. Indeed, the induced electrical field modulates the neural transmembrane
potentials and, thereby, neural activity. These effects depend on the intensity, frequency, and number
of pulses applied, the duration of the course, the coil location and the type of coil used. RTMS can be
applied as continuous trains of low-frequency (LF, 1 Hz) or bursts of higher frequency (HF, ≥5 Hz)
rTMS. In general, LF rTMS is thought to reduce, and HF rTMS is thought to enhance excitability in
the targeted cortical region [22–24]. The physiological impact of rTMS and other neuromodulatory
techniques involves synaptic plasticity, specifically long-term potentiation and long-term depression.
However, standard coils used in research and the clinic for rTMS are not capable of directly
stimulating deep brain regions. The Heased coil (H-coil) is likely to have the ability of deep brain
stimulation without the need of increasing the intensity to extreme levels [25]. Deep TMS (dTMS) thus
enables deeper noninvasive cortical stimulation at an effective depth of approximately 3 cm depending
on the coil’s design and the stimulation intensity.
There is a sufficient body of evidence to accept with level of recommendation A (definite efficacy,
Evidence Based Health Care) the analgesic effect of HF rTMS applied over the primary motor cortex
contralateral to pain and the antidepressant effect of HF rTMS applied over the DLPFC [24]. Overall,
rTMS techniques have been shown to have potential therapeutic efficacy in cognitive neuroscience [26].
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In turn, these techniques have attracted worldwide attention as possible therapeutic tools for various
neurological and psychiatric conditions [24,27].
3. Material and Methods
In order to identify relevant articles for this review, we searched the MEDLINE, accessed by
PubMed (1966–August 2018) and EMBASE (1980–August 2018) electronic databases were searched
using the medical subject headings (MeSH) and free terms: “repetitive transcranial magnetic
stimulation” OR “rTMS” AND “attention” OR “attentional” OR “attentive” AND “dorsolateral
prefrontal cortex” OR “DLPFC”. Only original research articles were considered eligible for inclusion.
Review articles or single case reports were excluded. The search was limited to studies written in
English. Studies that met the following criteria were included: rTMS was conducted to patients with
psychiatric diseases or neurological disorders with behavioral symptoms; administration site of rTMS
was the DLPFC; the effect of rTMS on the cognitive domain attention was examined. In contrast,
rTMS studies with animals as well as studies in which rTMS stimulation was administered on sites
other than the DLPFC were excluded. Moreover, we included only studies that focused exclusively
on attention, while studies with a broader scope within the umbrella concept of executive functions
were excluded.
Full-text articles were retrieved for the selected titles, and reference lists of the retrieved
articles were searched for additional publications. When data was missing or incomplete, principal
investigators of included trials were contacted and additional information was requested. The titles
and abstracts of the initially identified studies were screened by two authors to determine whether
they satisfied the selection criteria. The methodological quality of each study and risk of bias were
independently assessed, focusing on blinding, and any disagreement was solved through discussion.
This search strategy yielded 24 results, three of which were excluded after reading the full paper,
thereby leaving 21 studies which contributed to this review.
A flow-chart (Figure 1) shows the selection/inclusion process.
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Figure 1. Flow-chart showing the selection/inclusion process.
4. Results
The demographic characteristics of the patients in all included articles are shown in Table 1.
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Table 1. Demographic characteristics of the patients in the included studies.
Studies No Gender Mean Age Disease Duration Education
M/F (y) (y) (y)
Depression
Speer et al., 2001 [28] 18 - 45 ± 7 - -
Höppner et al., 2003 [29] 30 8/22 56.4 ± 11.1 - -
Januel et al., 2006 [30] 27 6/21 37.78 ± 11.27 77.77 ± 90.82 mo -
Levkovitz et al., 2009 [31]
23 H1 12/11 45.57 ± 13.34 13.96 ± 2.96 -
22 H2 11/11 45.77 ± 11.99 13.00 ± 2.12 -
11 HIL 110% 3/5 44.27 ± 11.36 15.45 ± 2.02 -
8 HIL 120% 10/10 49.88 ± 9.52 13.13 ± 2.81 -
Vanderhasselt et al., 2009a [32] 16 6/10 42 ± 11.2
Vanderhasselt et al., 2009b [33] 15 6/9 45.6 ± 5.87 - -
Ullrich et al., 2012 [34]
Active 22 31.8/68.2% 56.9/10.2% - -
Sham 21 42.9/57.1% 54.1/7.8%
Naim-Feil et al., 2016 [35] 21 10/11 44 ± 9 15 ± 3 -
Kavanaugh et al., 2018 [36] Active 43 10/31 45.84 ± 11.87 17.94 ± 3.7 -
Sham 41 12/31 47.95 ± 12.78 15.59 ± 9.17
Schizophrenia
Mittrach et al., 2010 [37]
Active 18 14/4 34.5 ± 0.5 5.7 ± 5.2 -
Sham 14 11/3 34.4 ± 10.5 5.6 ± 8.7
Guse et al., 2013 [38]
Active 13 10/3 37 (22-58) 15.5 -
Sham 12 9/3 36 (20-51 12.6
Prikryl et al., 2013 [39] Active 23 23/0 31.6 ± 8.04 4.91 ± 5.09 y 12.43 ± 2.06 y
Control 17 17/0 33.94 ± 9.98 5.89 ± 7.91 y 12.44 ± 1.97
Wölwer et al., 2014 [40]
Active 18 14/4 34.3 ± 5.7 5.7 ± 5.2 -
Sham 14 11/3 34.4 ± 5.6 5.6 ± 8.7
Attention deficit hyperactivity disorder
Bloch et al., 2010 [41]
13 7/6 - - -
Active 9 6/3 32 ± 11
Paz. et al., 2017 [42] Sham 13 8/5 30.85 ± 6.82 - -
Alzheimer disease
Wu et al., 2015 [43]
Active 26 10/16 71.4 ± 4.9 5.1 ± 1.5 11.4 ± 2.7 y
Control 26 11/15 71.9 ± 4.8 5.1 ± 1.5 11.5 ± 2.1 y
Autism
Sokhadze et al., 2010 [44] 13 12/1 15.6 ± 5.8 - -
Casanova et al., 2012 [45] 45 39/6 13 ± 2.7 - -
Sokhadze et al., 2018 [46] 112 93/19 13.1 ± 1.78 - -
Addiction
Herremans et al, 2015 [47] 26 17/9 45.2 ± 9.3 - -
Zang et al., 2018 [48] 31 31/0 43 ± 9.15 13 ± 7.45 -
no. = number of patients; M = male; F = female; y = years; mo. = months, “-“ not reported.
The description of the rTMS interventions in the reviewed articles is shown in Table 2.
Table 2. Description of the repetitive transcranial magnetic stimulation (rTMS) interventions in the
included studies.
Studies Stimulation Parameters OutcomeMeasures
Principal
Findings
Position Intensitity Frequency Total PulsesPer Session
No.
Sessions
Depression
Speer et al., 2001 [28] L DLPFC 100% MT 20 Hz1 Hz 1600 10
Continuous
Performance
Task
No significant
changes
Hoeppner et al., 2003 [29] L DLPFCR DLPFC 80% MT
20 Hz
1 Hz ? 10 d2 Test
No significant
changes
Januel et al., 2006 [30] R DLPFC 90% MT 1 Hz ? 16
Auditory and
visual attention
span
No significant
differences
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Table 2. Cont.
Studies Stimulation Parameters OutcomeMeasures
Principal
Findings
Position Intensitity Frequency Total PulsesPer Session
No.
Sessions
Levkovitz et al., 2009 [31] H-CoilDLPFC 120% MT 20 Hz 1689 20 CANTAB, RVP
↑ RVP
performances
Vanderhasselt et al., 2009a [32] L DLPFC 110% MT 10 Hz 1560 10
VAS
Self-paced
switching task
↑ Attentional
processes
Vanderhasselt et al., 2009b [33] L DLPFC 110% MT 10 Hz 1560 10 Self-pacedswitching task
↑ Attentional
control
Ullrich et al.; 2012 [34] L DLPFC 110% MT 30 Hz1 Hz
1800
990 15 ZVT, SKT
↑ Processing
speed
performance ↑
Naim-Feil et al., 2016 [35]
H-Coil
L > R
DLPFC
120% MT 20 Hz 1680 1 (n = 21)20 (n = 13) BDI, SART
↓ Sustained
attention deficits
Kavanaugh et al., 2018 [36]
2-coil
L > R
DLPF
120% MT 10 Hz 3000 20 CDR System ↑ Continuity andpower of attention
Schizophrenia
Mittrach et al., 2010 [37] L DLPFC 110% MT 10 Hz 1000 10 d2 Test No significantchanges
Guse et al., 2013 [38] L DLPFC 110% MT 10 Hz 1000 15 TAP
Significant
time-by-stimulation
interaction in
divided attention
Prikryl et al., 2013 [39] L DLPFC 110% MT 10 Hz 2000 15 SANS
↓ SANS total score
+ all domains of
negative
symptoms
Woelwer et al., 2014 [40] L DLPFC 110% MT 10 Hz 10000 10 d2 Test No significantchanges
Attention deficit hyperactivity disorder
Bloch et al., 2010 [41] R DLPFC 100% MT 20 Hz ? ?
PANAS, VAS
attention/mood
CANTAB
↑ VAS for
attention
Paz. et al., 2017 [42]
H-Coil
L/R
DLPFC
120% MT 18 Hz 1980 20 TOVA, CAARS
No differences
sham/active
rTMS
Alzheimer disease
Wu et al., 2015 [43] L DLPFC 80% RMT 20 Hz 1200 20
BEHAVE-AD,
ADAS-Cog
scores
Improvement in
all ADAS-Cog
scores
Autism
Sokhadze et al., 2010 [44] L DLPFC 90 % RMT 0,5 Hz 150 6
ABC, SCR, RBS
Early and late
ERP
components
Improvement of
error percentage
to targets P50
parieto-occipital↓,
frontal ↑
Casanova et al., 2012 [45] L/RDLPFC 90 % RMT ≤ 1 Hz 150 12
Selective
attention
illusory figures
ERP indices of
selective
attention
↓ in response
errors
↑ N200 and P300
components
Sokhadze et al., 2018 [46] L/RDLPFC 90 % RMT 1 Hz 180 18
Visual oddball
with Kanizsa
figures
Stimulus and
response-locked
ERP
↑Motor responses
accuracy
↑ Early and
later-stage ERP
indices
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Table 2. Cont.
Studies Stimulation Parameters OutcomeMeasures
Principal
Findings
Position Intensitity Frequency Total PulsesPer Session
No.
Sessions
Herremans et al, 2015 [47] R DLPFC 110 %RMT 20 Hz 1560 15 AUQ, OCDS
Cue-induced
alcohol craving
was not altered
Zang et al., 2018 [48] L DLPFC 90 % RMT 10 Hz 2000 14
Chinese
Affective Picture
System
Improvement of
emotional
attention in meth
addicts
Table legend: R = right; L = left; DLPFC = dorsolateral prefrontal cortex; MT = motor threshold;
CANTAB = Cambridge Neuropsychological Test Automated Battery; RVP = Rapid Visual Processing; VAS = Visual
Analogue Scale; ZVT = Zahlen-Verbindungs-Test; SKT = Syndrom-Kurztest; BDI = Beck depression Inventory;
SART = Sustained Attention to response task; CDR System = Cognitive Drug Research Computerized Assessment
System; TAP = Test of Attentional Performance; SANS = Scale for the Assessment of Negative Symptoms;
PANAS = Positive and Negative Affect Schedule; TOVA = Test of Variables of Attention; CAARS = Conners’ Adult
ADAH Rating Scale; BEHAVE-AD = Behavioral Pathology in Alzheimer’s Rating Scale; ADAS-Cog = Alzheimer’s
Disease Assessment Scale-Cognitive; ABC = Aberrant Behavior Checklist; SCR = Social Responsiveness Scale;
RBS = Repetitive Behavior Scale; AUQ = Alcohol Urge Questionnaire; OCDS = Obsessive Compulsive Drinking
Scale; ERP = event-related potentials; ↑ = enhancement; ↓ = reduction.
Healthy Individuals
The breakdown of specific brain areas or neurotransmitter systems leads to selective disruptions
of attentional networks in both healthy aging and pathological conditions [28]. The neural mechanisms
underlying the ability to divide attention between multiple sensory modalities are still poorly
understood [29].
The reviewed studies contribute to the understanding of the relationship between the DLPFC and
attentional control, and suggest possible therapeutic applications for HF or LF rTMS.
These findings are consistent with those from several experimental studies in healthy humans.
Both single tasks demanding focused attention and dual task conditions requiring divided
attention activate a widespread, mainly right-sided network including dorsolateral and ventrolateral
prefrontal structures, superior and inferior parietal cortex, and anterior cingulate gyrus [30]. Vohn
et al. performed fMRI in healthy subjects who underwent two within-modality (auditory/auditory,
visual/visual) and one cross-modality (auditory/visual) divided attention task, as well as related
selective attention control conditions [34]. The authors reported a significant activation in a
predominantly right hemisphere network involving the PFC, the inferior parietal cortex, and the
claustrum. Healthy subjects recognized fewer items after TMS over the left DLPFC than over the right
DLPFC during encoding under full attention, while they produced fewer items after TMS over the
right DLPFC in encoding under divided attention compared to a sham condition [31]. Taken together,
these results favor the view that the right DLPFC is of special importance for attention, except for the
last study which would point to a higher relevance of the left, compared to the right DLPFC.
It should be considered that selective and divided bimodal attention are concepts based on distinct
neural processes. In fact, selective attention involves modulation of activity in the sensory cortices,
while divided attention is achieved for most individuals via recruitment of the DLPFC [49].
TMS over PFC induced a significant reduction of performance time for both the verbal and
visuo-spatial tests, thus suggesting the importance of this area in performing tasks requiring a high
level of controlled attention [32].
Furthermore, 5 Hz rTMS over right DLPFC exerts remote effects on the activity of areas that
functionally interact with this area during attentional processes [33].
HF rTMS over the right DLPFC was suggested to have an effect on top-down attentional processes
by modulating the attentional set [35]. This is of interest, since top-down modulation mediated by
the prefrontal cortex is a causal link between early attentional processes and subsequent memory
performance [36].
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Divided attention performance was significantly impaired about 30–60 min after a single rTMS
session was applied over the left DLPFC, compared to a sham condition one week apart [26].
Daily HF-rTMS can improve attentional control in normally aging individuals [37]. Subjects who
received five daily stimulation sessions of 10 Hz HF rTMS over the left DLPFC showed improved
performance in reaction time during incongruent trials (i.e., those with distracting information) after
HF-rTMS treatment compared with pretreatment assessment.
5. Results
5.1. Depression
Several studies assessed cognitive performance effects in patients with depression receiving rTMS.
No major changes in the Continous Performace Task assessing attention and in other cognitive tests
were observed in the first study of Speer and colleagues after LF or HF rTMS administered over
the DLPFC [40]. Later studies assessed attention using psychometric tests, such as the d2 test, the
sustained attention in the Cambridge Neuropsychological Test Automated Battery (CANTAB), the Test
of Attentional Performance, and failed to find any significant effects of either HL or LF rTMS applied
over the DLPFC [38,39,44]. Only one study using H-coils demonstrated that unilateral prefrontal left
stimulation with H1/HIL-coils significantly improved the score on the rapid visual processing test as
measured with the CANTAB [45].
A systematic review and meta-analysis of outcomes on individual neuropsychological tasks from
sham-controlled RCTs where rTMS was administered to the DLPFC in depressed patients has recently
been published [46]. No significant effect size for improvements with active compared to sham rTMS
treatment was found.
For the purpose of this review, it is of interest that some studies used more specific tests to
assess attentional processes. In a double-blind, placebo-controlled, crossover, within subjects design
study, sixteen depressed patients performed a modified task switching paradigm, before and after
receiving HF rTMS versus placebo rTMS over the left DLPFC [41]. One session of HF rTMS over the left
DLPFC had a specific beneficial effect on task-switching performance, whereas mood remained stable.
The same research group also found that after 2 weeks of HF rTMS over the left DLPFC, depressive
symptoms improved in more than half of a therapy-resistant population [42]. After a single session,
mood did not improve but attentional control was increased solely within the group of treatment
responders. Of course, it needs to be considered that depression has very broad negative effects on
cognitive function, so that a relieving of depressive symptoms might in turn have overall positive
effects on cognition.
A more recent study examined whether acute and long-term HF deep rTMS to the DLPFC can
attenuate attentional deficits associated with Major Depressive Disorder [47]. Twenty-one patients
and 26 matched control subjects were characterized with the Beck Depression Inventory and the
Sustained Attention to Response Task (SART) at baseline. Patients were retested following a single
session and after 4 weeks of HF (20 Hz) deep rTMS applied to the DLPFC. To control for the practice
effect, the controls were reassessed with the SART two further times. The patients exhibited deficits in
sustained attention and cognitive inhibition. Both acute and long-term HF frontal repetitive dTMS
ameliorated sustained attention deficits in the patient group. Improvement after acute dTMS was
related to attentional recovery after long-term dTMS. It should be noted that longer-term improvement
in sustained attention was not related to antidepressant effects of dTMS treatment.
Kavanaugh et al. examined recently the neurocognitive results of a randomized, double-blind,
sham-controlled trial with an investigational 2-coil rTMS device [47]. The authors included patients
with antidepressant treatment or treatment-intolerant major depressive disorder. A significant effect of
active rTMS was observed for the quality of episodic memory, while there were no effects for continuity
and power of attention as well as for working memory.
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5.2. Schizophrenia
In patients with chronic schizophrenia, no significant change of cognitive performances, including
the d2 attention task to assess attentional capacity, was observed as the result of a HF rTMS
treatment [43]. Wölwer and coworkers also failed to find any significant cognitive effects in patients
with schizophrenia who received HF rTMS [50].
In another study with schizophrenia patients, excitatory rTMS applied to the DLPFC was found
to improve, among other cognitive functions, the selective and divided attention, as assessed by means
of the Tübinger Aufmerksamkeitsprüfung [51].
Active rTMS can lead to a statistically significant reduction on the Scale for the Assessment of
Negative Symptoms total score and of all domains of negative symptoms of schizophrenia, including
impaired attention [52].
5.3. Autism Spectrum Disorder
Event-related brain potentials (ERPs) provide high temporal resolution measures of neuronal
activity associated with several perceptual and cognitive processes. Sokhadze et al. assessed post-TMS
differences in 13 subjects with autism [53]. The authors examined amplitude and latency of early and
late attention-orienting frontal ERP components, indicating improved attentional processing. After
rTMS, the parieto-occipital P50 amplitude decreased to novel distractors but not to targets; also, the
amplitude and latency to targets increased for the frontal P50 while decreasing to nontarget stimuli.
Twenty-five subjects with autism spectrum disorder (ASD) were assessed in order to characterize
selective attention using illusory figures before and after 12 sessions of rTMS applied bilaterally to the
DLPFC [54]. This study was conducted in a controlled design where a waiting-list of 20 children with
autism spectrum disorder was examined with the same time-interval, but with no rTMS intervention.
A significant increase in amplitude of both N200 and P300 components as well as a significant reduction
in response errors as a result of rTMS were detected.
The same research group also found, in 124 high functioning ASD children, that 18 sessions of
rTMS applied over the DLPFC facilitates cognitive control, attention, and target stimuli recognition
by improving discrimination between task-relevant and task-irrelevant illusory figures in an oddball
test [55].
5.4. Attention Deficit Hyperactivity Disorder
In a crossover double-blind randomized, sham-controlled pilot study, patients with ADHD
received either a single session of HF rTMS directed to the right DLPFC (real rTMS) or a single session
of sham rTMS [56]. The post-real rTMS attention score improved significantly compared to the prereal
rTMS attention score. rTMS had no effect on measures of mood and anxiety, and sham rTMS showed
no effects.
In a more recent study, twenty daily sessions were conducted in patients diagnosed as having
ADHD, using the bilateral HF dTMS coil in order to stimulate the PFC. The Conners’ Adult ADHD
Rating Scale questionnaire and a computerized continuous performance test, the Test of Variables of
Attention, were used for the assessment of cognitive functions. No differences in clinical outcomes
were observed between groups receiving real dTMS or sham TMS [57].
5.5. Addiction
HF (10 Hz) rTMS of the left DLPFC was found to improve emotional attention of 31
methamphetamine addicts [58]. The attention bias effect to negative information persisted in the
active rTMS group over two weeks.
An fMRI study in 26 recently detoxified alcohol-dependent patients documented effects of
accelerated HF rTMS applied to the right DLPFC [59]. The findings suggest that the intervention did
not manifestly affect the craving neurocircuit during an alcohol-related cue-exposure, but instead it
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may have influenced the attentional network. In fact, brain activation changes after one and 15 HF
rTMS sessions were observed in regions associated with the extended reward system and the default
mode network, respectively, during the presentation of event-related alcohol cue-reactivity paradigms.
5.6. Alzheimer’s Disease
A single study has examined the effects of HF rTMS, applied over the DLPFC on behavioral and
psychological symptoms of dementia as well as on cognitive function in 52 patients with Alzheimer’s
disease (AD) [60].
The intervention group, which was treated with 20 Hz rTMS five days a week for four weeks,
showed significantly lower scores (i.e., greater improvement) than the control group on the Alzheimer’s
Disease Assessment Scale-Cognitive (ADAS-Cog) total score, as well as on all four ADAS-Cog factor
scores (memory, language, constructional praxis, and attention).
6. Discussion
This review highlights that rTMS applied over the DLPFC can positively influence the attentional
function in subjects with several psychiatric disorders. The outcome measures were not uniform but
mostly dealt with attentional performance.
Some studies revealed that prefrontal rTMS could exert procognitive effects on executive function
and attention in patients with depression [3]. Antidepressant effects of rTMS could be related to the
same neurochemical mechanisms that underlie cognitive functioning, or just facilitate the normal
cognitive function that was repressed because of the severe effects depression has on overall physical
and cognitive functioning. It has been hypothesized that the extent of antidepressant effects could
be considered as second-order long-term effects possibly related to primary alternations in cognitive
functioning. Concurrence of depression and cognitive dysfunctions is well known in a wide range of
clinical populations [61]. In particular, impaired cognition is closely related to depressive symptoms in
AD [62,63], thus possibly potentiating the devastating effects of the disease itself or being an early sign
of neural dysfunction [64].
In patients with schizophrenia, imaging studies have demonstrated abnormalities in the left
globus pallidus, which lead to widespread hypometabolism affecting the frontal lobes, especially the
DLPFC and the anterior cingulate gyrus [65]. Furthermore, abnormalities of visually orienting the
frontal lobes/executive attentional network could interact with the parietal lobes/orienting network
to affect the initiation of attentional shift, thus leading to abnormalities of visual orienting [66]. It is
therefore of interest that rTMS to the DLPFC could improve attentional functioning in this patient
population [38]. However, the findings were contradictory, as other studies could not identify any
beneficial effects. A more systematic investigation comparing the different parameters of TMS to each
other may shed more light on the mechanisms of action.
The results of some studies support the use of LF rTMS as a modulatory tool to alter the disrupted
balance between cortical excitation and inhibition in autism. LF rTMS application to DLPFC would
result in an alteration of the abnormal excitatory/inhibitory ratio through the activation of inhibitory
GABAergic double bouquet interneurons.
Similarly, in patients suffering from ADHD initial findings suggest the possibility that attentional
difficulties can be improved by using HF rTMS applied to the right DLPFC, and have encouraged future
research [41]. However, the evidence from a more recent study does not support the effectiveness
of bilateral prefrontal stimulation to treat adult ADHD [42]. Due to the small sample size, these
preliminary results should be interpreted with caution.
rTMS can significantly improve, among other cognitive functions, attentional impairment that
often accompanies AD. Impairments in visual attention and visual information processing have been
identified as part of the neuropsychological features of AD, even in its earliest stages, and dissociations
in visual attention deficits have been detected also in mild cognitive impairment (MCI) using a measure
that assesses simple, divided, and selective attention [67]. It is unclear whether the memory impairment
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in patients with amnestic MCI (aMCI) and AD is associated with attentional deficits. An fMRI study
revealed that there are changes in the functional network subserving divided attention in patients with
aMCI, as reflected in the attenuated activation of PFC [68]. Interestingly, depressive symptoms in AD
patients increase the deficits of cognitive flexibility and divided attention [69].
This review has some limitations. First of all, there is considerable variability between studies
in patients with different neuropsychiatric diseases. Very few trials have used exactly the same
study design. The stimulation protocols, with respect to frequency, intensity, orientation of the coil,
pattern, number of pulses by train, total number of pulses, duration of stimulation, frequency and
intensity of stimulation, number of sessions delivered, are highly heterogeneous. Therefore, estimating
the real effectiveness and reproducibility is very difficult. Systematic investigation of the effects of
the various stimulation protocols are highly warranted, because the border between effectiveness
and ineffectiveness may be very small and occurs somewhere in the dimensions spanned by the
abovementioned parameters.
Furthermore, we have included in this review only studies employing specific cognitive
tests/tasks focusing on attention, even if working memory and other executive functions are strongly
correlated with this cognitive domain. Indeed, the role of the right DLPFC and of the right posterior
parietal cortex (PPC) in controlling the interaction between working memory and attention during
a visual search has been explored using rTMS in a recent study [70]. Both the rDLPFC and the
right PPC were found to be critical for controlling working memory biases in human visual attention.
However, the broader scope of including executive functions should be addressed in another systematic
summarizing work; possibly a meta-analysis could be conducted given that the study protocols were
more comparable.
It should be considered that most therapeutic attempts are based on rTMS techniques aiming
at enhancing cortical excitability, in particular HF rTMS. However, the underlying pathophysiologic
mechanisms differ among the various neurological and psychiatric diseases which can be treated with
this noninvasive brain stimulation technique. Therefore, appropriate testing of cortical physiology
before and after therapeutic interventions is needed.
7. Conclusions
In conclusion, a better understanding of attention networks could allow targeting the most
suitable area of the brain according to the specific attention domain affected. Moreover, a detailed
examination of the best stimulation frequency, surface or deep stimulation, duration and intensity of
the intervention, among other important core features of TMS-protocols, should be done when moving
closer to clinical application of TMS to treat attentional deficits.
Despite the above-mentioned limitations, this review indicates that neuromodulatory techniques
such as rTMS are promising approaches to be used as attentional enhancers in people with
neuropsychiatric conditions where impaired attention is a prominent feature.
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